William R. Bell

Thrombolysis in myocardial infarction (TIMI) trial—Phase I: Hemorrhagic manifestations and changes in plasma fibrinogen and the fibrinolytic system in patients treated with recombinant tissue plasminogen activator and streptokinase

Anupama Rao, Craig M. Pratt, Andrew Berke et al. · Journal of the American College of Cardiology · 1988 · 988 citations

Medicine, Cardiology, Pharmacology +17

Autoxidation versus Covalent Binding of Quinones as the Mechanism of Toxicity of Dopamine, 6-Hydroxydopamine, and Related Compounds toward C1300 Neuroblastoma Cells in Vitro

Doyle G. Graham, S M Tiffany, William R. Bell et al. · Molecular Pharmacology · 1978 · 956 citations

Life Sciences, Biochemistry, Toxicology +13

Improved Survival in Thrombotic Thrombocytopenic Purpura–Hemolytic Uremic Syndrome

William R. Bell, Hayden G. Braine, Paul M. Ness et al. · New England Journal of Medicine · 1991 · 863 citations

Medicine, Hematology, Pharmacotherapy +12

Trousseau's syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features.

George H. Sack, Jack Levin, William R. Bell · PubMed · 1977 · 673 citations

Medicine, Hematology, Pathology +17

Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel

Charles L. Bennett, Jean M. Connors, John Carwile et al. · New England Journal of Medicine · 2000 · 646 citations

Medicine, Pharmacology, Pharmacotherapy +15